Kevin Waters
Net Worth

Last updated:

What is Kevin Waters net worth?

The estimated net worth of Mr. Kevin Waters is at least $17,714,074 as of 15 Oct 2024. He owns shares worth $3,802,519 as insider, has earned $12,780,795 from insider trading and has received compensation worth at least $1,130,760 in PROCEPT BioRobotics Corporation.

What is the salary of Kevin Waters?

Mr. Kevin Waters salary is $565,380 per year as Senior Vice President & Chief Financial Officer in PROCEPT BioRobotics Corporation.

How old is Kevin Waters?

Mr. Kevin Waters is 48 years old, born in 1977.

What stocks does Kevin Waters currently own?

As insider, Mr. Kevin Waters owns shares in one company:

Company Title Shares Price per share Total value
PROCEPT BioRobotics Corporation (PRCT) Senior Vice President & Chief Financial Officer 96,096 $39.57 $3,802,519

What does PROCEPT BioRobotics Corporation do?

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

Kevin Waters insider trading

PROCEPT BioRobotics Corporation

Mr. Kevin Waters has made 21 insider trades between 2023-2024, according to the Form 4 filled with the SEC. Most recently he sold 8,115 units of PRCT stock worth $592,557 on 15 Oct 2024.

The largest trade he's ever made was exercising 71,465 units of PRCT stock on 13 Dec 2023. As of 15 Oct 2024 he still owns at least 96,096 units of PRCT stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 8,115 $73.02 $592,557
Sale
Common Stock 15,959 $72.11 $1,150,803
Sale
Common Stock 926 $73.75 $68,293
Option
Common Stock 25,000 $4.56 $114,000
Option
Stock Option (Right to Buy) 25,000 $4.56 $114,000
Option
Stock Option (Right to Buy) 15,917 $4.52 $71,945
Sale
Common Stock 400 $83.35 $33,340
Option
Stock Option (Right to Buy) 9,083 $4.56 $41,418
Option
Common Stock 15,917 $4.52 $71,945
Sale
Common Stock 6,623 $81.96 $542,821
Option
Common Stock 9,083 $4.56 $41,418
Sale
Common Stock 17,977 $82.69 $1,486,518
Sale
Common Stock 1,024 $48.83 $50,002
Option
Stock Option (Right to Buy) 17,747 $4.56 $80,926
Option
Stock Option (Right to Buy) 36,010 $4.52 $162,765
Option
Common Stock 36,010 $4.52 $162,765
Option
Common Stock 17,747 $4.56 $80,926
Sale
Common Stock 3,435 $46.67 $160,311
Option
Stock Option (Right to Buy) 22,349 $4.52 $101,017
Option
Common Stock 22,349 $4.52 $101,017
Sale
Common Stock 22,349 $50.16 $1,121,071
Option
Stock Option (Right to Buy) 28,677 $4.52 $129,620
Sale
Common Stock 28,677 $50.09 $1,436,374
Option
Common Stock 28,677 $4.52 $129,620
Option
Common Stock 904 $4.52 $4,086
Option
Stock Option (Right to Buy) 904 $4.52 $4,086
Sale
Common Stock 904 $50 $45,200
Option
Stock Option (Right to Buy) 17,310 $4.52 $78,241
Option
Common Stock 17,310 $4.52 $78,241
Sale
Common Stock 17,310 $45.08 $780,248
Option
Common Stock 71,465 $4.52 $323,022
Sale
Common Stock 71,465 $40.05 $2,862,245
Option
Stock Option (Right to Buy) 71,465 $4.52 $323,022
Sale
Common Stock 6,888 $40.02 $275,637
Option
Common Stock 6,888 $4.52 $31,134
Option
Stock Option (Right to Buy) 6,888 $4.52 $31,134
Sale
Common Stock 3,837 $40 $153,480
Option
Common Stock 3,837 $4.52 $17,343
Option
Stock Option (Right to Buy) 3,837 $4.52 $17,343
Sale
Common Stock 4,360 $40.02 $174,492
Option
Common Stock 4,360 $4.52 $19,707
Option
Stock Option (Right to Buy) 4,360 $4.52 $19,707
Sale
Common Stock 22,631 $35.13 $794,914
Sale
Common Stock 706 $31.84 $22,479
Sale
Common Stock 22,046 $34.36 $757,545
Sale
Common Stock 7,136 $34.15 $243,709
Sale
Common Stock 818 $35.16 $28,758

PROCEPT BioRobotics key executives

PROCEPT BioRobotics Corporation executives and other stock owners filed with the SEC: